PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide, Used as an As ... - The Facts

Retrieved on: 2022-05-15 17:46:09

Tags for this article:

Click the tags to see associated articles and topics

PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide, Used as an As ... - The Facts. View article details on hiswai:

Excerpt

Respiratory & Immunology, part of BioPharmaceuticals, is one of AstraZeneca's main disease areas and is a key growth driver for the Company.

Article found on: thefacts.com